Negative Isolation of Th1 and Th2 Lymphocytes via Magnetic Bead Depletion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods lack a simple and efficient means to isolate Th1 and Th2 lymphocytes from human peripheral blood, which is crucial for various clinical studies and disease assessments, particularly in autoimmune and allergic conditions, where rapid access to 'clean' Th lymphocytes is essential.
Innovation Solution
A negative isolation method using specific monoclonal antibodies to selectively remove contaminating cells and erythrocytes from peripheral blood mononuclear cells, allowing for the separation of Th1 and Th2 lymphocytes through magnetic column separation, leveraging antibodies targeting distinct surface markers.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional isolation methods are used, then Th1 and Th2 lymphocytes can be obtained, but the isolation process is complex and time-consuming
Solution Approach 1:
The patent applies negative selection by removing all cell types except Th1 and Th2 lymphocytes, rather than directly isolating the target cells. This inversion of the isolation approach simplifies the method by using depletion strategies with magnetic beads and antibodies against non-target cells, achieving faster and cleaner separation of Th1/Th2 subsets from peripheral blood mononuclear cells
Solution Approach 2:
The patent uses a universal magnetic bead-based platform that can selectively deplete multiple cell types (B cells, NK cells, cytotoxic T cells, monocytes, erythrocytes) using different antibody-coated magnetic beads. This multi-functional system allows sequential removal of various non-target cells through the same basic magnetic separation apparatus, reducing overall process complexity while maintaining high purity of isolated Th1 and Th2 cells
2Loss of time
If conventional isolation methods are used, then Th1 and Th2 lymphocytes can be obtained, but the isolation process is time-consuming
Solution Approach 1:
The patent performs preliminary depletion of major non-T cell populations (B cells, NK cells, monocytes) before final Th1/Th2 separation. This staged approach with pre-coated magnetic beads and sequential depletion steps prepares the cell mixture in advance, reducing the time required for final isolation and enabling rapid access to pure Th1 and Th2 subsets for clinical studies
Solution Approach 2:
The patent uses magnetic beads coated with specific antibodies as intermediaries to facilitate rapid cell separation. These magnetic bead-antibody complexes bind to non-target cells, allowing quick magnetic separation from the target Th1 and Th2 lymphocytes. This intermediary system accelerates the isolation process while maintaining high purity, enabling clinical applications that require rapid cell preparation
3Manufacturing precision
If negative isolation method with multiple antibodies is used, then purity of Th1 and Th2 isolation is improved, but the procedure complexity increases
Solution Approach 1:
The patent segments the isolation process into distinct depletion stages: first depleting B cells, NK cells, and monocytes; then depleting cytotoxic T cells and erythrocytes; finally separating Th1 and Th2 subsets. Each stage uses specific antibody-coated magnetic beads targeting particular cell surface markers. This segmentation achieves high purity (>90% for Th1, >84% for Th2) while organizing the complex procedure into manageable, sequential steps that can be performed systematically
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves over 90% enrichment of Th1 cells and over 84% enrichment of Th2 cells, facilitating their use in disease diagnosis and prognosis, and enabling rapid access for clinical studies and immunotherapeutic applications.
Implementation Method 1
magnetic column separation
Implementation Method 2
specific monoclonal antibodies to selectively remove contaminating cells and erythrocytes
Data Source
AI summary
A negative isolation method for separately isolating preparations of Th1 and Th2 helper lymphocytes from peripheral blood mononuclear cells involving the use of novel combinations of monoclonal antibodies to separately sequester specific Th1 and Th2 lymphocytes and contaminating leukocytes and erythrocytes, adding a magnetic colloid to the cells, and using a magnetic column for fractionation of Th1 and Th2 cells. Imbalances in the relative numbers of Th1 and Th2 lymphocytes can be used in the diagnosis and prognosis of human diseases.